ImmunoGen, Inc. IMGN
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 8.72B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 86.75
- Beta
- 1.17
- Short ratio
- 3.78
- Inst. own
- 86.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 6, 2024
- 50-d avg
- 29.71
- 200-d avg
- 19.72
- 1y target
- 25.50
News
1 year ago globenewswire.com
Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits Research
The global antibody drug conjugates market size was valued at USD 11.84 billion in 2024 and is projected to reach from USD 12.89 billion in 2025 to USD 25.38 billion by 2033, growing at a CAGR of…
2 years ago investopedia.com
AbbVie Cuts Its Guidance on ImmunoGen Deal
Drug maker AbbVie (ABBV) is lowering its current quarter guidance because of costs related to its acquisition of ImmunoGen.
2 years ago marketwatch.com
AbbVie's stock dips premarket after it lowers Q1 guidance to reflect dilutive impact of ImmunoGen deal close
AbbVie Inc.'s stock ABBV, -0.41% fell 0.5% early Monday, after the drug company lowered its first-quarter guidance to reflect the dilutive impact of its closure of the acquisition of ImmunoGen. The…
2 years ago prnewswire.com
AbbVie Completes Acquisition of ImmunoGen
Adds flagship antibody-drug conjugate (ADC) ELAHERE® (mirvetuximab soravtansine-gynx) for folate receptor-alpha (FRα) positive platinum-resistant ovarian cancer (PROC) to AbbVie's portfolio…
2 years ago zacks.com
Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?
Here is how ImmunoGen (IMGN) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year.
2 years ago zacks.com
ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock?
ImmunoGen (IMGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the…
2 years ago investorplace.com
7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024
As 2023 wrapped up, Russell 2000 stocks, mirroring the dynamics of small-to-mid-cap companies, showed resilience, outperforming their initial stance. The iShares Russell 2000 ETF (NYSEARCA: IWM ), a…
2 years ago businesswire.com
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
2 years ago zacks.com
How ImmunoGen (IMGN) Stock Stands Out in a Strong Industry
ImmunoGen (IMGN) has seen solid earnings estimate revision activity over the past two month, and belongs to a strong industry as well.
2 years ago cnbc.com
Cramer names biopharma companies to watch as industry mergers start to pile up
CNBC's Jim Cramer pointed out the numerous mergers and acquisitions across the biopharma industry.
2 years ago zacks.com
All You Need to Know About ImmunoGen (IMGN) Rating Upgrade to Strong Buy
ImmunoGen (IMGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
2 years ago zacks.com
Best Momentum Stocks to Buy for January 4th
IMGN and GTLB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 4, 2024.
2 years ago zacks.com
New Strong Buy Stocks for January 4th
IMGN, GTLB, FNWD, BL and TMHC have been added to the Zacks Rank #1 (Strong Buy) List on January 4, 2024.
2 years ago businesswire.com
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
2 years ago fool.com
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
AbbVie needs to diversify its drug portfolio because of the loss of exclusive rights to Humira. The recent acquisition of ImmunoGen fills several needs and comes at an excellent time.
2 years ago investorplace.com
3 Stocks at the Forefront of Medical Innovation
Innovation in the medical world is undoubtedly a fundamental pillar in the development of humanity. There are great companies within the biotech sector doing wonderful work, research, and…
2 years ago zacks.com
5 Reasons to be Bullish into 2024
2023: Predicting is Futile, Interpreting is Priceless
2 years ago businesswire.com
ImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASH
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Presents Findings from Newly Diagnosed AML Cohorts in Phase 1b/2 Study of Pivekimab Sunirine with Azacitidine and Venetoclax at ASH.
2 years ago investorplace.com
Market Movers: Why Big Players Are Investing Millions in These 3 Stocks
Certain smart money stocks catch the discerning eye of big players in investing, drawing in substantial investments. Delving into the strategies and growth patterns of three companies reveals…
2 years ago reuters.com
Abbvie to focus on smaller deals after Cerevel and ImmunoGen buyout
U.S. drugmaker Abbvie said on Thursday it does not expect any transactions similar to its $8.7 billion buyout of Cerevel Therapeutics in the foreseeable future and would instead focus on smaller…
-
2 years ago benzinga.com
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.
-
2 years ago benzinga.com
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
-
3 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
-
3 years ago benzinga.com
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.
-
3 years ago benzinga.com
Eli Lilly, Livent, Super Micro Computer And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
-
3 years ago benzinga.com
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.
-
3 years ago benzinga.com
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
-
3 years ago benzinga.com
HUYA, Tencent Music Entertainment, Taiwan Semiconductor Manufacturing, And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
-
3 years ago benzinga.com
Earnings Scheduled For November 4, 2022
Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $0.49 per share on revenue of $49.95 million. • Telefonica (NYSE:TEF) is likely to report earnings…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 951 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows.
-
4 years ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 39 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million.
-
5 years ago benzinga.com
Earnings Scheduled For May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.
-
5 years ago benzinga.com
52 Weeks High Article 0.004831689889895241
Stocks That Hit 52-Week Highs On Friday Before 10 a.m. ET on Friday, 202 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Friday's session saw 466 companies set new 52-week highs.
-
6 years ago benzinga.com
50 Stocks Moving In Monday's Mid-Day Session
Gainers MyoKardia, Inc. (NASDAQ: MYOK) shares climbed 58.2% to $220.80 after Bristol-Myers Squibb announced a multi-billion dollar deal to buy cardio-focused biopharma Myokardia.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
7 years ago benzinga.com
26 Stocks Moving In Wednesday's Pre-Market Session
26 Stocks Moving In Wednesday's Pre-Market Session
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018
Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
-
9 years ago benzinga.com
22 Stocks Moving In Wednesday's Pre-Market Session
22 Stocks Moving In Wednesday's Pre-Market Session
-
9 years ago benzinga.com
15 Biggest Mid-Day Gainers For Monday
15 Biggest Mid-Day Gainers For Monday